Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PAB | Ann: Appendix 4C - Quarterly - 30 September 2024 | 30/10/24 | 4 | 1.4K | |||
|
|||||||
PAB | Ann: PAT-DX1 clinical development update | 30/10/24 | 78 | 28K | |||
|
|||||||
PAB | Ann: Notice of Annual General Meeting/Proxy Form | 21/10/24 | 0 | 291 | |||
|
|||||||
PAB | Ann: Notification of cessation of securities - PAB | 14/10/24 | 0 | 384 | |||
|
|||||||
PAB | Ann: PAT-DX1 GMP specification testing update | 30/09/24 | 26 | 8.5K | |||
|
|||||||
PAB | Ann: PAT-DX1 GMP specification testing update | 20/09/24 | 56 | 19K | |||
|
|||||||
PAB | Ann: Further update on PAT-DX1 GMP manufacturing run | 28/08/24 | 103 | 31K | |||
|
|||||||
PAB | Ann: Appendix 4E and 2024 Annual Report | 24/08/24 | 4 | 1.9K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |